GENZYME THERAPEUTIC PRODUCTS LIMITED PARTNERSHIP – Trademark Portfolio

Entity Type: 13

GENZYME THERAPEUTIC PRODUCTS LIMITED PARTNERSHIP holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 2 filings in this category. Currently, 1 trademark is registered. Notable registered marks include CEREZYME. The owner is based in CAMBRIDGE, MA.

500 KENDALL STREET

CAMBRIDGE, MA 02142

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

CEREZYME
CEREZYME
Registered 1994
CEREDASE
CEREDASE
Cancelled 1988

Trademark Classifications

GENZYME THERAPEUTIC PRODUCTS LIMITED PARTNERSHIP's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (2 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does GENZYME THERAPEUTIC PRODUCTS LIMITED PARTNERSHIP have?

GENZYME THERAPEUTIC PRODUCTS LIMITED PARTNERSHIP has 2 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 cancelled.

What trademark classes does GENZYME THERAPEUTIC PRODUCTS LIMITED PARTNERSHIP file in?

GENZYME THERAPEUTIC PRODUCTS LIMITED PARTNERSHIP files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are GENZYME THERAPEUTIC PRODUCTS LIMITED PARTNERSHIP's most well-known trademarks?

GENZYME THERAPEUTIC PRODUCTS LIMITED PARTNERSHIP's registered trademark portfolio includes well-known marks such as CEREZYME. These are among 1 currently registered trademark in the portfolio.

What is GENZYME THERAPEUTIC PRODUCTS LIMITED PARTNERSHIP's trademark registration success rate?

GENZYME THERAPEUTIC PRODUCTS LIMITED PARTNERSHIP has a 50% trademark registration rate, with 1 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.